Sheffield Teaching Hospitals NHS Foundation Trust has received national recognition for its efforts to reduce medicines waste, following the success of a pharmacy-led initiative aimed at improving sustainability and efficiency in patient care. The trust’s Medicines Assessment for Discharge (MA4D) scheme was named a finalist in the Environmental Sustainability category at the HFMA National Healthcare Finance Awards in 2026.
The programme focuses on reviewing patients’ existing medication supplies before discharge, ensuring that only necessary medicines are issued. By avoiding duplication, the initiative addresses a longstanding challenge within the NHS - overprescribing and unnecessary dispensing at the point of discharge. The recognition highlights the growing importance of sustainability within healthcare, particularly as the NHS seeks to reduce both financial waste and environmental impact.
Measurable impact on cost, carbon and care
The impact of the MA4D scheme has been both immediate and substantial. In January 2025 alone, the trust dispensed 1,849 fewer medicines compared with the same month the previous year. Over the first five months of implementation, the reduction in unnecessary dispensing delivered estimated savings of around £55,000, demonstrating the financial benefits of improved medicines management.
The environmental gains are equally significant. The trust estimates that the initiative prevented approximately 77 tonnes of CO₂ emissions in 2025, largely by reducing the need to manufacture, transport and dispose of unused medicines. Given that medicines account for roughly a quarter of the NHS’s total carbon footprint, reducing waste in this area is seen as a critical component of the health service’s broader net zero strategy. In addition to cost and carbon savings, the initiative has improved patient safety by reducing the risk of stockpiled or out-of-date medications being used after discharge.
Digital workflows and data-driven pharmacy practices
From a health technology perspective, the success of the MA4D scheme reflects the increasing role of digital workflows and data-driven decision-making in medicines optimisation. The initiative relies on improved communication between pharmacy teams, ward staff and patients, supported by digital systems that track medication histories and availability. By providing clinicians with better visibility of what medicines a patient already has at home, the system enables more informed prescribing decisions.
This aligns with wider NHS efforts to integrate pharmacy data into electronic patient records and shared care systems, ensuring that medication information is accessible across different care settings. Digital tools also play a role in identifying patterns of overprescribing and waste, enabling organisations to target interventions more effectively. In this context, the Sheffield programme demonstrates how relatively simple process changes—when supported by data—can deliver significant improvements.
Improving discharge efficiency and patient experience
The initiative has also had a positive impact on hospital discharge processes, an area of ongoing pressure across the NHS. By ensuring that discharge prescriptions are based on accurate information about existing medication supplies, the scheme has helped to reduce delays in preparing medicines, enabling patients to leave hospital more quickly.
This contributes to improved patient flow, freeing up beds and reducing waiting times for incoming patients. For patients, the benefits extend beyond speed. The approach supports more personalised care, as clinicians engage directly with patients and carers to understand their medication needs and circumstances. This collaborative approach helps to build trust and ensures that patients leave hospital with the right medicines—and only the medicines—they need.
A model for sustainable healthcare innovation
The recognition of Sheffield Teaching Hospitals’ initiative reflects a broader shift within the NHS towards sustainable healthcare practices that deliver value across clinical, financial and environmental dimensions. Programmes like MA4D demonstrate how innovation in operational processes can contribute to national priorities, including cost control, carbon reduction and improved patient outcomes. The trust has a track record of sustainability initiatives, including projects aimed at reducing waste in clinical environments and improving resource efficiency. By embedding sustainability into everyday clinical practice, organisations can achieve meaningful change without requiring large-scale capital investment.
Wider implications for NHS digital and pharmacy strategy
The success of the scheme also has implications for the future of pharmacy services within the NHS. As the health service continues to invest in digital infrastructure, there is increasing potential to scale similar approaches across multiple organisations. Integrated care systems could use shared data platforms to standardise medicines optimisation processes, reducing variation and improving outcomes at a regional level. In addition, the use of analytics and AI could further enhance medicines management, identifying patients at risk of overprescribing or non-adherence and supporting targeted interventions.
Looking ahead
Following its national recognition, there is likely to be interest in replicating the Sheffield model across other NHS trusts. Scaling the approach will require a combination of digital capability, workforce engagement and organisational commitment, ensuring that systems are in place to support accurate data sharing and collaborative working.
For the health technology sector, the initiative highlights how digital tools and data-driven processes can support sustainability as well as clinical improvement. By reducing waste, improving efficiency and enhancing patient safety, Sheffield Teaching Hospitals has demonstrated a practical and scalable approach to one of the NHS’s most persistent challenges. As the health service continues to pursue its net zero ambitions, innovations like MA4D are likely to play an increasingly important role, showing that small, targeted interventions can deliver significant system-wide benefits.
